e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Treatment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
F. Kanat, H. Vatansev, T. Teke (Konya, Turkey)
Source:
Annual Congress 2007 - Treatment of COPD
Session:
Treatment of COPD
Session type:
Thematic Poster Session
Number:
585
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Kanat, H. Vatansev, T. Teke (Konya, Turkey). The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 30: Suppl. 51, 585
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007
Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Fluid homeostasis in chronic obstructive lung disease
Source: Eur Respir J 2003; 22: 33S-40S
Year: 2003
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting
Year: 2010
Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 586s
Year: 2005
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 485s
Year: 2001
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
The utility of brain natriuretic peptide in patients with stable chronic lung diseases
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept